| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.39▲ | 3.37▲ | 3.37▲ | 3.47▼ | 3.29▲ |
| MA10 | 3.30▲ | 3.29▲ | 3.27▲ | 3.48▼ | 3.51▼ |
| MA20 | 3.09▲ | 3.04▲ | 2.99▲ | 3.23▲ | 3.60▼ |
| MA50 | 3.16▲ | 3.26▲ | 3.31▲ | 3.54▼ | 2.36▲ |
| MA100 | 3.53▼ | 3.64▼ | 3.72▼ | 3.44▲ | 2.37▲ |
| MA200 | 4.07▼ | 3.88▼ | 3.68▼ | 2.39▲ | 4.72▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.055▲ | 0.073▲ | 0.090▲ | 0.043▲ | -0.113▼ |
| RSI | 68.873▲ | 66.213▲ | 63.964▲ | 52.257▲ | 53.998▲ |
| STOCH | 96.649▲ | 96.925▲ | 97.325▲ | 77.797 | 37.236 |
| WILL %R | -11.111▲ | -8.197▲ | -5.405▲ | -16.203▲ | -72.258 |
| CCI | 131.267▲ | 123.258▲ | 101.420▲ | 14.861 | -52.220 |
| ▼ GAP | $ATHE Open Gap Down %2 | Set Alert |
|
Wednesday, April 30, 2025 04:35 AM
Highlights Reported positive topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) led by robust clinical efficacyPhase 2 data featured in an ...
|
|
Monday, April 28, 2025 04:36 AM
MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a ...
|
|
Monday, April 28, 2025 04:36 AM
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 3.36 | 3.45 | 3.3114 | 3.45 | 12,572 |
| 30/04/25 | 3.37 | 3.48 | 3.37 | 3.46 | 5,551 |
| 29/04/25 | 3.49 | 3.49 | 3.49 | 3.49 | 3,890 |
| 28/04/25 | 3.56 | 3.56 | 3.30 | 3.48 | 10,848 |
| 25/04/25 | 3.42 | 3.55 | 3.42 | 3.4806 | 8,057 |
| 24/04/25 | 3.41 | 3.54 | 3.41 | 3.54 | 2,758 |
| 23/04/25 | 3.4799 | 3.56 | 3.44 | 3.51 | 12,277 |
| 22/04/25 | 3.41 | 3.50 | 3.3187 | 3.47 | 10,307 |
| 21/04/25 | 3.49 | 3.4901 | 3.3401 | 3.4534 | 14,257 |
| 17/04/25 | 3.43 | 3.50 | 3.3101 | 3.50 | 9,069 |
|
|
||||
|
|
||||
|
|